When obesity is desirable: A longitudinal study of the Miami HIV-1- infected drug abusers (MIDAS) cohort

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 23, Issue 1, 2000, Pages 81-88

  Shor Posner, Gail ^a   Campa, Adriana ^a   Zhang, Guoyan ^a   Persaud, Navindra ^a   Miguez Burbano, Maria Jose ^a   Quesada, Jose ^a   Fletcher, Mary Ann ^a   Page, J Bryan ^a   Baum, Marianna K ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Drug use; HIV infection; Mortality; Obesity

Indexed keywords

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; SURVIVAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034088997     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200001010-00011     Document Type: Article

References (49)

1. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985;42:1255-65.
2. Serwadda D, Mugerwa RD, Sewankamboo NK, et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985;2:849-52.
3. Kotler DP, Tierney AR, Wang J, Pierson RN. Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7.
4. Palenicek JP, Graham NMH, He YD, et al. Weight loss prior to clinical AIDS as a predictor of survival. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:366-73.
5. Wheeler DA, Gilbert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:80-5.
6. Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression. AIDS 1995;9:1051-6.
7. Tang AM, Graham NM, Chandra RK, Saah AJ. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997;127:345-51.
8. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:370-74.
9. Semba RD, Graham N, Caiaffa WT, Margolick JB, Vlement L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type I infection. Arch Intern Med 1993;153:2149-54.
10. Baum MK, Shor-Posner G, Zhang G, et al. HIV-1 infection in women is associated with severe nutritional deficiencies. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:370-4.
11. Shor-Posner G, Baum MK. Nutritional alterations in HIV-1 seropositive and seronegative drug users. Nutrition 1996;12:555-6.
12. Beach RS, Mantero-Atienza E, Shor-Posner G, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992; 6:701-8.
13. Wolf AM, Colditz GA. Social and economic effects of body weight in the United States. Am J Clin Nutr 1996;63(suppl): 466S-9S.
14. Stallone DD. The influence of obesity and its treatment on the immune system. Nutr Rev 1994;52:37-50.
15. Chandra RK, Kutty KM. Immunocompetence in obesity. Acta Paediatr Scand 1980;69:25-30.
16. Nieman DC, Henson DA, Nehlsen-Cannarella SL, et al. Influence of obesity on immune function. J Am Diet Assoc 1999;99:294-9.
17. Tanaka S, Inoue S, Isoda F, et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes 1993;17:631-6.
18. McMurray DN, Beskitt PA, Newmark SR. Immunologic status in severe obesity. Int J Obes 1982;6:61-8.
19. Nieman DC, Nehlsen-Cannarella SI, Henson DA, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord 1996;20:353-60.
20. Kreek MJ. Immune function in heroin addicts and former heroin addicts in treatment: pre- and post-AIDS epidemic. NIDA Res Monogr 1990;96:192-219.
21. Pirozhkov SV, Watson RR, Chen GJ. Ethanol enhances immunosuppression induced by cocaine. Alcohol 1992;9:489-94.
22. Carpenter CCJ, Fischl M, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998. JAMA 1998;280:78-86.
23. Parker J, Adelsberg B, Boone D, et al. Leukocyte immunophenotypy by flow cytometry in a multisite study: standardization quality control and normal values in the transfusion safety study. Clin Immunol Immunopathol 1990;55:187-220.
24. Baron GC, Klimas NG, Fischl MA, et al. Decreased natural killer cell mediated cytotoxicity per effector cell in AIDS. Diagn Immunol 1985;3:197-204.
25. Fletcher MA, Baron GC, Ashman MA, et al. Use of whole blood methods in assessment of immune parameters in immunodeficiency status. Diagn Immunol 1987;5:69-81.
26. Fletcher MA, Klimas NG, Morgan R, Gjerset G. Lymphocyte proliferation assays. In: Rose N, ed. Manual of clinical laboratory immunology, 4th ed. Washington, DC: American Society of Microbiology 1992:213-9.
27. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985;41:810-17.
28. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. Lean body mass estimation by biolectrical impedance analysis; a four-site cross-validation study. Am J Clin Nutr 1988;47:7-14.
29. Shetty PS, Jung RT, Stampler M, et al. Rapid turnover transport proteins: an index of subclinical protein-energy malnutrition. Lancet 1979;2:230-2.
30. Whetter PA, Ullrey DE. Improved fluorometric method for determining selenium. J Assoc Off Anal Chem 1978;61:927.
31. Willet WC, Sampson L, Stampler M, et al. Reproducity and validity of a semi-quantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.
32. Smit E, Graham NMH, Tang A, Flynn C, Solomon L, Vlahov D. Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition 1996;12:496-50.
33. Shor-Posner G, Basil A, Lu Y, et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med 1993;94:515-19.
34. Moriguchi S, Oonishi K, Kato M, Kishino Y. Obesity is a risk factor for deteriorating cellular immune functions with aging. Nutr Res 1995;15:151-60.
35. Melchior JC. Metabolic aspects of HIV associated wasting. Biomed Pharm 1997;51:455-60.
36. Semba RD, Caiaffa WT, Graham NMH, Cohn S, Vlahov D. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis 1995;171:1196-1202.
37. Carlson MG, Snead WL, Campbell PJ. Fuel and energy metabolism in fasting humans. Am J Clin Nutr 1994;60:29-36.
38. Grunfeld C, Pang M, Shimizu L, et al. Resting energy expenditure, caloric intake and weight in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992;55:455.
39. Bouchard C, Pérusse L. Genetics of obesity. Annu Rev Nutr 1993; 13:337-54.
40. Bouchard C, Tremblay A, Després JP, et al. The response to long-term overfeeding in identical twins. N Engl J Med 1990;322:1477-82.
41. Neel JV. A thrifty genotype rendered detrimental by progress. Am J Hum Genet 1962;14:353-62.
42. Whitney EN, Rolfes SR. Lipids: triglycerides, phospholipids and sterols. In: Understanding nutrition, 8th ed. Belmont, CA; International Thompson Publishing Co, 1999:143.
43. Slusarczyk R. The influence of the human immunodeficiency virus on resting energy expenditure. J Acquir Immune Defic Syndr 1994; 7:1025-7.
44. Watson RR, Mohs ME. Effects of morphine, cocaine, and heroin on nutrition. In: Seminara D, Watson RR, Pawlowski A, eds. Alcohol, immunomodulation and AIDS. New York: Alan R. Liss, 1990;413-18.
45. Morabia A, Fabre J, Chee E, Zeger S, Orsat E, Robert A. Diet and opiate addiction: a quantitative assessment of the diet of noninstitutionalized opiate addicts. Br J Addict 1989;84:173-80.
46. Huggins ND, Khaled MA, Cornwell PE, Alvarez JO. Nutritional status and immune function in cocaine and heroin abusers and in methadone treated subjects. Res Commun Subst Abuse 1991;12: 209-14.
47. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving protease inhibitors. AIDS 1998;12:51-8.
48. Dong KL, Bausserman LL, Flynn MM, et al. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). JAIDS J Acquir Immune Defic Syndr 1999;21:107-13.
49. Kreek MJ. Immune function in heroin addicts and former heroin addicts in treatment pre- and post-AIDS epidemic. NIDA Res Monogr 1990;96:192-219.